z-logo
open-access-imgOpen Access
E-cigarettes: promise or peril?
Author(s) -
Erich W. Russi
Publication year - 2015
Publication title -
swiss medical weekly
Language(s) - English
Resource type - Journals
eISSN - 1424-7860
pISSN - 1424-3997
DOI - 10.4414/smw.2015.14187
Subject(s) - medicine , traditional medicine
Electronic cigarettes (e-cigarettes) are battery-operated devices that produce a vapour consisting of nicotine (although some are nicotine-free), propylene glycol or glycerol, and flavourings. E-cigarettes were invented in 2003 in China and entered the United States and European markets in 2006 [1]. Hence, it is obvious that no observational data on the long-term health effects of e-cigarettes exist as yet. Data on the health consequences of chronic nicotine exposure is available from studies in prolonged users of nicotine replacement products [2]. These data do not suggest that chronic nicotine exposure increases cardiopulmonary or cancer risk. Toxic and carcinogenic compounds may be found in e-cigarettes, but in trace amounts that are much lower than levels found in conventional cigarettes. E-cigarettes do not expose the user to most of the constituents of cigarette smoke at concentrations that are responsible for many of the tobacco-attributable diseases. Therefore, most experts believe that inhaling e-cigarette vapour is less harmful than inhaling cigarette smoke. The limited available evidence suggests a potential for e-cigarettes as a smoking cessation tool and/or an instrument for reducing conventional cigarette use (harm reduction concept) [3]. During the past few years e-cigarettes have gained popularity, primarily among smokers who want to reduce the risk of smoking [4]. The paper from Guillet S. et al. [5] adds some information about the perception and the use of ecigarettes. The authors performed a cross-sectional survey in 2013 among 300 students and instructors of the French school of military paramedical personnel using self-administered questionnaires. They found a prevalence of smoking among the 200 responders of 40%, which is higher than in the general French population. In tobacco smokers the observed e-cigarette lifetime use prevalence was 57% and was close to the 50% of smokers observed in the general population. However, the daily use prevalence was much lower, at 4% in the study population and 3% in the French population. The motivation for e-cigarette use in smokers was the intention to reduce tobacco consumption in 43% and to quit smoking in 8%. But almost half of the responders reported a decrease in tobacco consumption following e-cigarette initiation (average decrease of 5 to 10 cigarettes). Only about half of all respondents, smokers and nonsmokers, perceived e-cigarettes as being less harmful than tobacco. A 30to 40-times higher number of adults (age ≥18 years) were surveyed in the US [6]. This annual consumer-based web survey comprised 6 555 persons in 2010–2011 and 8 173 between 2012-2013. Among smokers, an increase in ever use of e-cigarettes from 9.8% to 36.5% was found, and an increase in current (i.e. past 30-day) use from 4.9% to 9.4%. Of importance is the fact that among never smokers ever use remained unchanged (1.3%–1.2%). A recent Swiss survey among approximately 5 000 persons in 2013 found considerably lower numbers: 6.7% had ever used an e-cigarette during their lifetime, 5.5% of daily smokers had consumed e-cigarettes during the past month before the survey and only 0.4% were daily users [7]. The following reasons may be responsible for e-cigarette use not becoming more popular in tobacco cigarette smokers and may explain the difference between the numbers of ever users and of current users of e-cigarettes. – Awareness and sound knowledge on vaping remain at a disappointing level in the general population and even in smokers. – Smokers quite often become frustrated with e-cigarettes, since they do not purchase the appropriate vaping devices, are using liquids with a too low nicotine concentration and are not informed about adjusting their inhalation technique. – E-cigarettes in their current form are less satisfactory than tobacco cigarettes, since they do not have the same nicotine-delivery profile. The “ideal e-cigarette” has not been invented yet. E-cigarettes and future nicotine delivery products have the potential to make an important, and even game-changing, contribution to public health by helping heavily nicotine dependent persons to reduce the number of tobacco cigarettes smoked and eventually to stop smoking.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom